Top Markets
Coin of the day
InnoCan Pharma Corporation InnoCan Pharma Corporation

InnoCan Pharma Corporation

INNO
Rang in Aktien #33465
InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to... InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems that integrate cannabidiol (CBD) with other pharmaceutical compounds. Its operations and development efforts span across the United States, Poland, France, and various international markets. The company actively pursues research and development into treatments for conditions such as COVID-19, leveraging CBD delivered via exosomes and liposomes. InnoCan's product line features a range of CBD-infused topical items, including eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Beyond R&D, the corporation is also involved in the marketing and distribution of its proprietary CBD-enhanced pharmaceutical and cosmetic offerings. Established in 2018, InnoCan Pharma Corporation maintains its principal office in Calgary, Canada.
Aktienkurs
$1.69
Zuletzt synchronisiert: 2026-08-13
Marktkapitalisierung
$7.59M
Veränderung (1 Tag)
2.22%
Veränderung (1 Jahr)
-84.04%
Land
CA
Handel InnoCan Pharma Corporation (INNO)

Kategorie

Preis INNO mit Marktkapitalisierung von B
InnoCan Pharma Corporation InnoCan Pharma Corporation
INNO
$1.69
Marktkapitalisierung von InnoCan Pharma Corporation(INNO)
Marktkapitalisierung: $7.59M
Mit Stand August 2026 hat InnoCan Pharma Corporation eine Marktkapitalisierung von $7.59M. Das macht InnoCan Pharma Corporation laut unseren Daten zum 33465th wertvollsten Unternehmen der Welt nach Marktkapitalisierung. Die Marktkapitalisierung ist der Gesamtmarktwert aller ausstehenden Aktien eines börsennotierten Unternehmens und wird häufig verwendet, um den Unternehmenswert zu bestimmen.
Marktkapitalisierung von InnoCan Pharma Corporation von 2019 bis 2026
INNO im Vergleich zu den Top 5 der beliebtesten stocks
Preis für INNO Vermögenswert B Marktkapitalisierung von B Ergebnisse
InnoCan Pharma Corporation InnoCan Pharma Corporation
$1,211,812 $7.59M
$5.452T +71,787,367.58%
InnoCan Pharma Corporation InnoCan Pharma Corporation
$998,018 $7.59M
$4.490T +59,122,239.92%
InnoCan Pharma Corporation InnoCan Pharma Corporation
$925,197 $7.59M
$4.162T +54,808,393.81%
InnoCan Pharma Corporation InnoCan Pharma Corporation
$817,158 $7.59M
$3.676T +48,408,138.53%
InnoCan Pharma Corporation InnoCan Pharma Corporation
$629,713 $7.59M
$2.833T +37,303,988.36%